Consistent with our findings, aberrant IL-1 signaling and inflammasome activation is suspected to contribute to the pathogenesis of ADs such as lupus [reviewed in Kahlenberg and Kaplan (61)]. This evidence concerns the gene IL1B and systemic lupus erythematosus.